Literature DB >> 10555753

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer.

F Desgrandchamps1, M Teren, L Dal Cortivo, J P Marolleau, P Bertheau, J M Villette, A Cortesse, P Teillac, A Le Duc, F C Hamdy.   

Abstract

This study was undertaken to evaluate the risk of haematogenous dissemination of epithelial cells induced by endoscopic resection and/or cystoprostatectomy for transitional cell carcinoma of the bladder. Thirty-three patients were studied. Thirty-one had different stages and grades of bladder cancer and two patients had benign bladder conditions. Twenty-five cancer patients required transurethral resection of their bladder tumour. Of those, 20 had superficial disease (pTaG1-G2: n = 19; pT1G2: n = 1) and five had muscle invasive tumours (pT2G3: n = 2; pT3aG3: n = 1; pT4G3: n = 2). Five patients underwent radical cystoprostatectomy for muscle invasive cancers (pT2G3: n = 3; pT3bG3: n = 1; pT4G3: n = 1) and one man received chemotherapy for metastatic disease. Venous blood (10 ml) was obtained from the antecubital fossa in each patient, before and 1-2 h after completion of surgery, and prior to treatment in the metastatic patient. An indirect immunocytochemical technique was used to detect circulating epithelial cells after centrifugation on Ficoll gradient and fixation of mononuclear cells on slides, using a monoclonal antibody directed against three cytokeratins: CK8, CK18 and CK19. Circulating epithelial cells were detected only in the patient with metastatic disease. None of the other patients had evidence of epithelial circulating cells before or after surgery. The results suggest that irrespective of disease stage and grade, neither endoscopic nor open bladder surgery leads to detectable dissemination of urothelial cells in the peripheral circulation. These procedures are therefore unlikely to increase the risk of progression and metastasis in transitional cell carcinoma of the bladder.

Entities:  

Mesh:

Year:  1999        PMID: 10555753      PMCID: PMC2374308          DOI: 10.1038/sj.bjc.6690771

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.

Authors:  P Stieber; N Schmeller; C Schambeck; K Hofmann; W Reiter; U Hasholzner; A Fateh-Moghadam
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

2.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.

Authors:  A Zippelius; P Kufer; G Honold; M W Köllermann; R Oberneder; G Schlimok; G Riethmüller; K Pantel
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

4.  Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer.

Authors:  Y Senga; G Kimura; T Hattori; K Yoshida
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

5.  Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy.

Authors:  P Eschwège; F Dumas; P Blanchet; V Le Maire; G Benoit; A Jardin; B Lacour; S Loric
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

6.  Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy.

Authors:  M G Oefelein; K Kaul; B Herz; M D Blum; J M Holland; T C Keeler; W A Cook; J M Ignatoff
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

7.  Induction of tumour cell shedding into effluent venous blood breast cancer surgery.

Authors:  A Choy; P McCulloch
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

8.  Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.

Authors:  S A Burchill; M F Bradbury; K Pittman; J Southgate; B Smith; P Selby
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

Review 9.  Cytokeratins and tissue polypeptide antigen.

Authors:  B E Sundström; T I Stigbrand
Journal:  Int J Biol Markers       Date:  1994 Apr-Jun       Impact factor: 3.248

10.  Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma.

Authors:  T Yuasa; T Yoshiki; T Tanaka; C J Kim; T Isono; Y Okada
Journal:  Jpn J Cancer Res       Date:  1998-09
View more
  6 in total

Review 1.  Detection and isolation of circulating tumor cells in urologic cancers: a review.

Authors:  Robert D Loberg; Yaron Fridman; Brian A Pienta; Evan T Keller; Laurie K McCauley; Russell S Taichman; Kenneth J Pienta
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

2.  Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer.

Authors:  Evi Comploj; Christopher B Dechet; Michael Mian; Emanuela Trenti; Salvatore Palermo; Michele Lodde; Christine Mian; Andrea Ambrosini-Spaltro; Wolfgang Horninger; Armin Pycha
Journal:  World J Urol       Date:  2013-10-29       Impact factor: 4.226

Review 3.  The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.

Authors:  Michael Rink; Heidi Schwarzenbach; Sabine Riethdorf; Armin Soave
Journal:  World J Urol       Date:  2018-10-26       Impact factor: 4.226

Review 4.  Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis.

Authors:  Pavlos Msaouel; Michael Koutsilieris
Journal:  BMC Cancer       Date:  2011-08-04       Impact factor: 4.430

Review 5.  The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.

Authors:  Sabine Riethdorf; Armin Soave; Michael Rink
Journal:  Transl Androl Urol       Date:  2017-12

6.  The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.

Authors:  Zheng Zhang; Wei Fan; Qiaoling Deng; Shihui Tang; Ping Wang; Peipei Xu; June Wang; Mingxia Yu
Journal:  Oncotarget       Date:  2017-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.